IjB kinase a (IKKa), one of the two catalytic subunits of the IKK complex involved in nuclear factor jB (NF-jB) activation, also functions as a molecular switch that controls epidermal differentiation. This unexpected function requires IKKa nuclear translocation but does not depend on its kinase activity, and is independent of NF-jB signalling. Ikka -/-mice present with a hyperproliferative and undifferentiated epidermis characterized by complete absence of a granular layer and stratum corneum. Ikkadeficient keratinocytes do not express terminal differentiation markers and continue to proliferate even when subjected to differentiation-inducing stimuli. This antiproliferative function of IKKa is also important for the suppression of squamous cell carcinogenesis. The exact mechanisms by which nuclear IKKa controls keratinocyte proliferation and differentiation remained mysterious for some time. Recent studies, however, have revealed that IKKa is a major cofactor in a TGFb-Smad2/3 signalling pathway that is Smad4 independent. This pathway controls cell cycle withdrawal during keratinocyte terminal differentiation. Although these are not the only functions of nuclear IKKa, this multifunctional protein is a key regulator of keratinocyte and epidermal differentiation and a critical suppressor of skin cancer.
Introduction
The epidermis, the outermost part of the skin, is a stratified and keratinized squamous epithelium mainly composed of keratinocytes, which forms a protective barrier. Epidermal differentiation, which starts in the mouse at embryonic day (E) 12, leads to formation of several distinct cell layers characterized by their ultrastructure, mitotic state and expression of specific molecular markers (Fuchs and Byrne, 1994; . The basal layer develops from the surface ectoderm at approximately E9.5 in the mouse. The p63 gene, which specifies different isoforms of a transcription factor related to tumour suppressor p53, controls basal layer formation and maintenance as well as IkB kinase a (IKKa) expression (Candi et al, 2007; . Basal keratinocytes, including epidermal stem cells and transit-amplifying cells, are cuboidal, express cytokeratins (CKs) 5 and 14 and have a high proliferative potential . These cells form the embryonic periderm (M'Boneko and Merker, 1988) , which is lost on establishment of the epidermal barrier. At E12 in the mouse, the basal cells give rise to the intermediate cell layer located between the embryonic basal layer and the periderm (Smart, 1970; Weiss and Zelickson, 1975) . The intermediate cells divide several times before they withdraw from cell cycle and mature into postmitotic spinous cells (Smart, 1970; . By contrast, adult basal keratinocytes directly become spinous cells when terminal differentiation is initiated, without involvement of an intermediate cell type . The spinous layer is characterized by a switch in keratin expression, from CK5 and CK14 to CK1 and CK10 (Fuchs and Green, 1980) . Involucrin, a marker of early terminal differentiation is also synthesized in the upper part of this layer. The spinous cells continue their differentiation and maturation to form the granular layer, which is characterized by keratohyalin granules and expression of the late differentiation markers loricrin and filaggrin (Candi et al, 2005) . Terminal differentiation gives rise to the cornified layer (stratum corneum), which consists of extremely flat, keratinfilled and anucleated keratinocytes, called corneocytes, which are mummified within a lipid matrix (Candi et al, 2005; Segre, 2006) . The stratum corneum is primarily responsible for the barrier function of the skin (Elias, 2004; Segre, 2006) , which is established around E17.5 in mouse (Hardman et al, 1998) . Although major progress has been made in understanding the molecular changes that characterize epidermal differentiation, less is known about the signalling pathways that control these events. Here, we provide an overview of the current understanding of the central function of IKKa in the control of epidermal differentiation, homoeostasis and tumorigenesis.
Defective epidermal morphogenesis in

Ikka-deficient mice
The oligomeric IKK complex is composed of two catalytic subunits, IKKa and IKKb (DiDonato et al, 1997; Mercurio et al, 1997; Woronicz et al, 1997; Zandi et al, 1997) , and a regulatory subunit named IKKg or NEMO (nuclear factor kB (NF-kB) essential modulator) (Rothwarf et al, 1998; Yamaoka et al, 1998) . This complex is the key mediator of NF-kB activation in response to proinflammatory and innate immune challenges (Rothwarf et al, 1998) . Although IKKa and IKKb share considerable sequence identity, it is IKKb that usually serves the more critical function in the activation of classical NF-kB signalling (Tanaka et al, 1999; Li et al, 1999b, c) . To determine the unique functions of IKKa, several groups have disrupted the Ikka locus in mice and were surprised to find that it has an essential function in epidermal differentiation and morphogenesis (Hu et al, 1999; Li et al, 1999a; Takeda et al, 1999) . Newborn Ikka -/-mice present with multiple morphological defects, including shiny and translucent skin, absence of erupted whiskers, shortened limbs and truncated snout and tail (Figure 1 ) (Hu et al, 1999; Takeda et al, 1999; Yoshida et al, 2000) . These mice develop to term but die shortly after birth, probably as a consequence of a major skin barrier defect that results in severe dehydration.
The Ikka -/-epidermis is characterized by the presence of basal and suprabasal layers, both in a highly proliferative state, and complete absence of the granular and the cornified layers ( Figure 2A ) (Hu et al, 1999; Takeda et al, 1999) . At the molecular level, these anomalies are characterized by the expression of CK5 and CK14 as well as proliferating cell markers, such as CK6, PCNA (proliferating cell nuclear antigen) and Ki67 in basal and suprabasal layers (Hu et al, 1999; Takeda et al, 1999) . In contrast, CK1 and CK10 are appropriately expressed in the first suprabasal layers of the Ikka -/-epidermis (Hu et al, 1999; Takeda et al, 1999) . Involucrin is also synthesized in the upper part of the suprabasal layer of these mice (Takeda et al, 1999) , indicating that an early step in the differentiation process still takes place, although late terminal differentiation markers, including loricrin and filaggrin, are not expressed (Hu et al, 1999; Takeda et al, 1999) ( Figure 2B ). It was suggested that the highly proliferative suprabasal cells of the Ikka -/-epidermis, which express CK1 and CK10, are reminiscent of intermediate cells rather than spinous cells . Hence, the most critical function of IKKa may be induction of cell cycle exit needed for converting basal and intermediate keratinocytes to spinous cells. When this step fails, all subsequent differentiation states are aborted (Figure 3 ).
Nuclear IKKa controls terminal differentiation of keratinocytes
Control of epidermal proliferation and differentiation by IKKa does not involve its protein kinase function and is completely independent from NF-kB activation (Hu et al, 2001 ). Ikka -/-keratinocytes do not exhibit a primary defect in NF-kB activation (Hu et al, 1999; Takeda et al, 1999) . In contrast, Ikka -/-keratinocytes display higher IKK and NF-kB activities than wild-type (WT) cells after incubation with either tumour necrosis factor-a or interleukin-1 (Hu et al, 2001 ). The observations that transgenic mice overexpressing a dominant inhibitor of NF-kB function (IkBaM) in the epidermis or mice lacking both RelA and c-Rel display epidermal hyperplasia that does not disrupt terminal differentiation and stratum corneum formation (Seitz et al, 1998; Gugasyan et al, 2004; Zhang et al, 2004) , are consistent with the NF-kB-independent action of IKKa in the epidermis.
As observed in vivo, isolated Ikka -/-keratinocytes are hyperproliferative and do not respond to differentiationinducing signals such as confluence or high Ca 2 þ (Hu et al, 1999 (Hu et al, , 2001 ). Ikka -/-keratinocytes, however, do differentiate in vitro when transduced by an adenovirus expressing a 'kinase-dead' form of IKKa, indicating that the kinase function is dispensable for keratinocyte differentiation (Hu et al, 2001) . Instead, IKKa needs to enter the nucleus to induce keratinocyte cell cycle arrest and terminal differentiation (Sil et al, 2004) . Nuclear entry depends on a nuclear localization sequence (NLS) within the IKKa kinase domain, the disruption of which prevents the induction of keratinocyte Figure 1 Macroscopical presentation of WT and Ikka -/-mice.
differentiation (Sil et al, 2004 ). An NLS is absent from IKKb, which cannot substitute for IKKa in keratinocyte differentiation and growth arrest. IKKa is also nuclear in basal and suprabasal cells of the epidermis (Descargues et al, 2008 ) and the oral epithelium (Maeda et al, 2007) , findings that are consistent with the cell culture results. The function of IKKa in the keratinocyte nucleus is linked to the production of a yet-to-be identified soluble factor or group of factors termed keratinocyte differentiation-inducing factor (kDIF) that can induce the expression of terminal differentiation markers, even in Ikka -/-cells (Hu et al, 2001) . Consistent with the existence of kDIF, transplantation of Ikka -/-skin onto the back of immuodeficient WT mice allows the Ikka-deficient epidermis to undergo normal differentiation, suggesting that the requirement for IKKa can be bypassed by factors produced by normal skin (Hu et al, 2001) . These experiments do not exclude the possibility that another important source of kDIF or similarly acting factors are dermal fibroblasts, which are well known to produce factors that control epidermal morphogenesis (Wessells, 1977) . In support of this hypothesis, a keratinocyte-specific Ikka disruption results in a less severe epidermal differentiation defect with altered skin barrier function than the total Ikka knockout (Gareus et al, 2007) . These results were interpreted to suggest that Ikka functions non-autonomously in the dermis to control epidermal differentiation. However, Ikka-deficient keratinocytes from the epidermalspecific knockout mouse still fail to differentiate in vitro We propose that the main function of IKKa is to induce cell cycle exit of intermediate keratinocytes when they mature into spinous cells. (Gareus et al, 2007) , similar to keratinocytes from total Ikka knockout mice (Hu et al, 2001) . Collectively, these results indicate that IKKa functions within epidermal keratinocytes and probably in dermal fibroblasts to induce keratinocyte differentiation. As keratinocyte-restricted expression of IKKa, unlike the keratinocyte-specific knockout, does not result in a differentiation defect (Sil et al, 2004) , it appears that the keratinocyte is the major site of IKKa action with respect to keratinocyte differentiation and epidermal-directed morphogenetic events.
IKKa is a critical component of a Smad4-independent TGFb-Smad2/3 signalling pathway
The most immediate effect of IKKa re-expression in Ikka -/-keratinocytes is cell cycle withdrawal, which precedes the expression of differentiation markers (Hu et al, 2001) . Thus, to understand the molecular function of IKKa, we searched for cell cycle-related target genes, the expression of which is IKKa dependent. This search netted several genes encoding negative cell cycle regulators, the expression of which is downregulated in Ikka -/-keratinocytes and epidermis, including Mad1 and Ovol1 (Descargues et al, 2008) , which encode negative regulators of Myc. The c-Myc oncogene is thought to influence the balance between keratinocyte proliferation and differentiation, depending on the intensity and timing of its activity (Watt et al, 2008) . Mad1 is a basic region/helix-loop-helix/leucine zipper transcriptional regulator that dimerizes with Max to form Mad:Max heterodimers that antagonize the transcriptional function of Myc:Max dimers (Ayer et al, 1993; Grandori et al, 2000) . Mad1
-/-mice, however, are viable, phenotypically normal (Foley et al, 1998; Grandori et al, 2000) and do not show any epidermal defect. Most likely, other Mad genes, including Mad2, Mad3 and Mad4, are functionally redundant with Mad1 and compensate for its loss. Indeed Mad2 and Mad3 are also induced in keratinocytes in an IKKa-dependent manner (unpublished data). Ovol1 is a zinc-finger-containing transcription factor, which, similar to Mad1, is also expressed in differentiating suprabasal keratinocytes (Dai et al, 1998; Descargues et al, 2008) . Ovol1 -/-adult mice present with aberrant hair formation but normal epidermal differentiation (Dai et al, 1998) . However, the suprabasal epidermis of Ovol1 -/-embryos shows increased proliferation and in vitro, Ovol1
-/-keratinocytes fail to exit the cell cycle in response to growth-inhibitory signals, such as high Ca 2 þ or TGFb (Nair et al, 2006) . This defect may be explained in part by abnormal upregulation of c-Myc, which is a direct target of Ovol1 in keratinocytes (Nair et al, 2006) . Thus, IKKa controls keratinocyte proliferation and cycling through the regulation of several Myc antagonists to allow keratinocytes to embark on their differentiation pathway (Figure 4) . Interestingly, another TGFb-related mechanism involving Smad3/4 and E2F4/5 transcription factors has been shown earlier to directly inhibit c-Myc expression in keratinocytes (Chen et al, 2002) (Figure 4 ). Although this signalling pathway triggers antiproliferative effects of TGFb in keratinocytes, its impact on keratinocyte differentiation is unknown.
Mad1 and Ovol1 are involved in the inhibition of keratinocyte proliferation induced by TGFb family members (Vastrik et al, 1995; Gomis et al, 2006) , suggesting a link between IKKa and the TGFb signalling pathway. TGFb family members, including TGFbs, activins and BMPs, are cytokines that control cell growth, differentiation and deposition of extracellular matrix through binding to heterodimeric cell surface receptor complexes composed of type I and II subunits, and intracellular Smad transcription factors (Shi and Massague, 2003; Feng and Derynck, 2005; Schmierer and Hill, 2007) . The eight mammalian Smad proteins are divided into three distinct groups: receptor-activated Smads (R-Smads: Smad1, Smad2, Smad3, Smad5 and Smad8), a unique common Smad mediator (Co-Smads: Smad4) and inhibitory Smads (i-Smads: Smad6 and Smad7). On ligand binding, the type II receptor activates the type I receptor through its kinase domain, and the type I receptor in turn phosphorylates R-Smads. The activated R-Smads form heterodimeric complexes with Smad4, which accumulate in the nucleus and directly repress or activate specific target genes (Shi and Massague, 2003; Feng and Derynck, 2005; Schmierer and Hill, 2007) .
TGFb family members, their receptors and Smad transcription factors are abundantly expressed in epidermal keratinocytes, suggesting homoeostatic and regulatory functions (He et al, 2001; Li et al, 2003) . Phosphorylated Smad2 and Smad3 proteins are concentrated in the nuclei of basal and suprabasal keratinocytes, whereas nuclear Smad4 staining is more preeminent in basal cells (Descargues et al, 2008) . Nonetheless, alterations of TGFb signalling in transgenic/ knockout mice have often resulted only in minor epidermal defects, thereby obscuring its exact functions in this tissue (Li et al, 2003) . We recently found that IKKa interacts strongly with Smad3 and weakly with Smad2, but does not bind Smad4 (Descargues et al, 2008) . IKKa associates with the C-terminal MH2 domain of Smad3 through its kinase domain (unpublished observations). The R-Smad MH2 domain is known to be essential for trans-activation, phosphorylation by type I receptors and Smad4 binding (Massague, 2000; Feng and Derynck, 2005) . On stimulation by TGFb1, IKKa and Smad3 form a transcriptional complex that accumulates in the keratinocyte nucleus to directly control the transcription of Mad1 (Descargues et al, 2008) . Similar findings were made Figure 4 TGFb-related signalling pathway controlling Myc activity in keratinocytes. The IKKa-Smad2/3 axis induces Mad1 and Ovol 1 expression on TGFb stimulation. These proteins may inhibit the activity and expression of Myc, inducing in turn keratinocyte cycle exit and differentiation. Interestingly, a TGFb-Smad3/4 signalling pathway, which is not associated with IKKa, but functions in cooperation with E2F4/5 transcription factors, has also been shown to negatively control c-Myc expression in keratinocytes (Chen et al, 2002) .
for Ovol1 (unpublished data). In Ikka -/-keratinocytes stimulated with TGFb1, Smad3 is no longer recruited to the Mad1 regulatory region despite its normal association with Smad4. Furthermore, nuclear staining for activated Smad2 and Smad3 is dramatically diminished in the Ikka -/-epidermis (Descargues et al, 2008) . Taken together, these results indicate that IKKa is required for nuclear accumulation and chromatin recruitment of phosphorylated Smad2 and Smad3 to IKKa-regulated genes in response to TGFb1. Interestingly, activin A, an important regulator of epidermal differentiation , is involved in the induction of Mad1 expression in keratinocytes (Werner et al, 2001) . As a result, one may speculate that the IKKa-Smad2/3 complex forms and activates anti-Myc genes, including Mad1, on activin A signals. As activin A also downregulates the Id1, Id2 and Id3 genes in keratinocytes (Rotzer et al, 2006) , it could also be interesting to analyse whether this signalling pathway depends on IKKa. Finally, we found that kDIF functions downstream of the IKKa-Smad2/3 signalling pathway as it can induce differentiation of Ikka -/-keratinocytes without inducing Mad1 expression ( Figure 5 ). Exactly how kDIF functions and what it is composed of remain to be determined.
The results mentioned above provided the first clear evidence for a critical function for Smad transcription factors in epidermal differentiation. Although Smad3 deficiency alone does not result in any cutaneous defect (Zhu et al, 1998; Datto et al, 1999; Yang et al, 1999) and the loss of Smad2 leads to early embryonic lethality (Nomura and Li, 1998; Waldrip et al, 1998; Weinstein et al, 1998; Heyer et al, 1999) , loricrin and filaggrin expression is barely detectable in E15.5 embryos lacking both Smad3 alleles and one Smad2 allele in their epidermis (Descargues et al, 2008) . Similarly, siRNA-mediated Smad2 knockdown in Smad3-deficient keratinocytes inhibited the expression of loricrin and filaggrin, as well as Mad1, in response to high Ca 2 þ (Descargues et al, 2008) . These results suggest that Smad2 and Smad3 are functionally redundant. The importance of the TGFbSmad2/3-IKKa axis for proper epidermal differentiation is also underscored by the analysis of transgenic mice in which the i-Smad Smad7 is inducibly expressed in the epidermis, resulting in defective expression of loricrin and filaggrin and failed stratum corneum formation (Descargues et al, 2008) . Consequently, these mutant mice display epidermal hyperplasia due to abnormal proliferation of suprabasal keratinocytes and loss of nuclear IKKa and Mad1 (Descargues et al, 2008) .
Surprisingly, this new TGFb response pathway centred around Smad2/3-IKKa complex formation is independent of Smad4. Smad4-deficient keratinocytes display normal Mad1 expression (Descargues et al, 2008) and undergo terminal differentiation in response to high Ca 2 þ (unpublished data). These results are consistent with the phenotype of mice with epidermal-specific deletion of Smad4 (Smad4 D/D mice). These mice present with degeneration of hair follicles and dermal cysts that progress to skin tumours in old animals, but do not show any perturbated epidermal differentiation and stratum corneum formation (Yang et al, 2005; Qiao et al, 2006) . Furthermore, activated Smad2 and Smad3, as well as IKKa, are normally localized in the nuclei of Smad4 D/D keratinocytes, which display normal Mad1 expression (Descargues et al, 2008) . Taken together, these results strongly indicate that Smad4 is not required for epidermal differentiation. The Smad4 independence of the TGFbSmad2/3-IKKa signalling pathway is reminiscent of another TGFb signalling operative during erythroid development in which TIF1g (also called TRIM33 or ectodermin) replaces Smad4 . However, TIF1g is a RING-type ubiquitin ligase that can target Smad4 to degradation and can therefore function as a negative regulator of Smad4-dependent TGFb signalling (Dupont et al, 2005) . Hence the exact function of TIF1g in TGFb signalling is not fully understood, and it is not known whether it affects the IKKadependent pathway.
IKKa and squamous cell carcinoma
IKKa was recently identified as a tumour suppressor in squamous cell carcinoma (SCC) (Liu et al, 2006; Maeda et al, 2007) . SCC is a cancer derived from squamous epithelia of the skin (epidermis), head and neck tissues (mouth, throat, oral and nasal cavities, esophagus) as well as other sites. SCC is the second most common skin cancer in Caucasians with an estimated incidence of 100 000-150 000 new cases per year in the United States (Johnson et al, 1992) . Sun exposure and immune suppression increase the risk of SCC development and so does tobacco use (Rudolph and Zelac, 2004; Hampton, 2005) . SCC of the oral cavity is one of the most prevalent cancers of the head and neck region with a worldwide incidence of 300 000 new cases per year, the Figure 5 Mad1 expression is not induced by kDIF-mediated keratinocyte differentiation. Conditioned medium from WT keratinocytes, which contains kDIF as shown earlier (Hu et al, 2001 ), failed to induce Mad1 expression in Ikka -/-keratinocytes while leading to keratinocyte differentiation as indicated by filaggrin expression. Only the re-expression of IKKa in Ikka -/-keratinocytes infected with adenovirus encoding this protein (Ad-IKKa) induces Mad1 expression.
occurrence of which is linked to tobacco use and betel nut chewing (Silverman, 2001) . SCCs of the oral cavity are more aggressive than those developing from the skin, and are associated with a 5-year survival rate of about 50-55% (Silverman, 2001) .
Molecular changes in SCCs are characterized by a marked heterogeneity and include activation of oncogenes, such as RAS, MYC, EGFR and Cyclin D1, as well inactivation of tumour suppressors, including p53 and p16 (Hardisson, 2003) . These genetic alterations are thought to influence malignant keratinocyte behaviour and tumour progression, but the precise molecular pathogenesis of SCC is poorly understood. Interestingly, mutations in exon 15 of the IKKa locus were described in a few high-grade and poorly differentiated human SCCs of the skin and were shown to be associated with reduced IKKa expression (Liu et al, 2006) . However, it seems that downregulation of IKKa due to epigenetic silencing of the IKKa locus is a more common occurrence seen in close to 30% of invasive oral SCCs (Maeda et al, 2007) . It was also reported that overexpression of IKKa in the suprabasal compartment, which results in increased epidermal differentiation and reduced keratinocyte proliferation, inhibits chemically induced SCC formation and progression in mice (Liu et al, 2006) . These results, together with enhanced SCC incidence in Ikka þ /-mice subjected to twostage skin carcinogenesis and loss of Ikka heterozygosity in the tumours, provide evidence that IKKa is a tumour suppressor in the epidermis (Liu et al, 2006; Park et al, 2007) . This function of IKKa is probably mediated through the control of keratinocyte proliferation. The loss of nuclear IKKa contributes to malignant conversion of keratinocytes into less differentiated and proliferative carcinoma cells. However, a recent study has suggested that increased IKKa may be found in acantholytic SCC (ASCC) (MorenoMaldonado et al, 2008) , an histologic variant of SCC showing positive staining for CKs (Rinker et al, 2001) . Unfortunately, the authors of that study have not carefully analysed whether ASCCs present with loss of nuclear IKKa, which would make their results more consistent with other studies mentioned above. SCC and other carcinoma cells are known to overproduce TGFb1 to modify their microenvironment through local immunosupression, extracellular matrix remodelling and neoangiogenesis, and these changes are required for tumour progression and invasiveness (Oft et al, 1996 (Oft et al, , 1998 Siegel and Massague, 2003; Li et al, 2005a Li et al, , 2006 . At the same time, carcinoma cells become resistant to TGFb-induced growth arrest (Siegel and Massague, 2003; Li et al, 2005a Li et al, , 2006 . Altered IKKa function may contribute, at least in part, to acquired resistance to TGFb1-induced growth arrest.
Conclusions and future directions
Although IKKa was first identified as a catalytic subunit of the IKK complex, which mediates NF-kB activation (DiDonato et al, 1997; Mercurio et al, 1997; Regnier et al, 1997; Zandi et al, 1997) , it has quickly emerged as a multifunctional protein with several unexpected and surprising activities. In the epidermis, IKKa has turned out to be a critical regulator of keratinocyte proliferation, differentiation and oncogenic transformation, and this function is completely unrelated to its protein kinase activity or NF-kB signalling. Instead, IKKa functions as a cofactor for Smad2/3 in a Smad4-independent pathway that inhibits keratinocytes proliferation (Descargues et al, 2008) (Figure 6 ). In this capacity, IKKa is required for the induction of a specific subset of TGFb-responsive genes that include the Myc antagonists Mad1 and Ovol1, but is not needed for other well-known TGFb target genes, such as p21, p15 and p27, encoding inhibitors of cyclin-dependent kinases (CDKs) (Descargues et al, 2008) . This is reminiscent of the two different classes of antiproliferative gene responses: Myc repression and inhibition of CDKs, respectively, that are induced during TGFb-mediated cell cycle arrest . It is attractive to speculate that the tumour suppressive function of IKKa is exerted through this pathway as well.
Other proteins may be part of the TGFb-Smad2/3-IKKa signalling pathway, as revealed by two mouse models with functional alterations of 14-3-3s (repeated epilation mutant mice) and IRF6, the disruption of which faithfully mimics the phenotype of Ikka -/-mice (Herron et al, 2005; Li et al, 2005b; Ingraham et al, 2006; Richardson et al, 2006 ). 14-3-3s belongs to a family of adaptors that can interact with target proteins in a sequence-specific manner, although its exact function is poorly understood (Mhawech, 2005) . It was reported that IKKa may protect the 14-3-3s locus from hypermethylation in keratinocytes by interacting with histone H3 . In that study, the authors showed that 14-3-3s is downregulated in Ikka -/-keratinocytes, suggesting that this gene is a downstream target of IKKa . The human IRF6 locus is defective in Van der Woude (VWS, OMIM: 119300) and popliteal pterygium (PPS, OMIM: 11500) syndromes, which are characterized by orofacial defects such as cleft lip and palate (Kondo et al, 2002) . IRF6 belongs to a family of transcription factors that share a highly conserved helix-turn-helix DNA-binding domain and a less conserved protein-binding domain. Interestingly, this protein-binding domain is related to the C-terminal MH2 domain of Smad proteins and has been referred to SMIR (Smad and IRF) domain (Eroshkin and Mushegian, 1999) . As DNA binding by Smad transcription factors depends on their association with other DNA-bound transcription factors (Derynck and Zhang, 2003; ten Dijke and Hill, 2004) , one can speculate that IRF6 may be a component of the Smad2/3-IKKa transcriptional complex that accumulates in the keratinocyte nucleus to induce the obligatory cell cycle exit that precedes terminal differentiation ( Figure 6 ). In addition, IKKa may also interact with other transcription factors, such as RARs to control epidermal barrier formation (Gareus et al, 2007) . The identification of other IKKa-interacting proteins and additional IKKa target genes will provide an ever better understanding of how this critical regulator of epidermal proliferation and differentiation carries out its daily work.
